CT-based immune radiomic signature for prognosis and prediction of immunotherapy and anticancer drug response in NSCLC.
Saved in:
| Title: | CT-based immune radiomic signature for prognosis and prediction of immunotherapy and anticancer drug response in NSCLC. |
|---|---|
| Authors: | Ma J; Department of CT Imaging, Nanyang Central Hospital, Nanyang, China., Guo K; Department of Pharmacy, Affiliated Hospital of Hebei University of Engineering, Handan, China., Gao Y; Department of Medicine and Health, Handan Vocational College of Science and Technology, Handan, China., Li T; Department of CT Imaging, Nanyang Central Hospital, Nanyang, China., Li F; Department of CT Imaging, Nanyang Central Hospital, Nanyang, China., Pang C; Department of Medicine and Health, Handan Vocational College of Science and Technology, Handan, China., Geng Y; Department of CT Imaging, Nanyang Central Hospital, Nanyang, China., Guo J; Department of Pharmacology, School of Medicine, Yangtze University, Jingzhou, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Apr 29; Vol. 17, pp. 1767389. Date of Electronic Publication: 2026 Apr 29 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1767389 |
